We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $936M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
+11.59%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$509M
AUM Growth
+$104M
Cap. Flow
+$50.7M
Cap. Flow %
9.95%
Top 10 Hldgs %
65.66%
Holding
55
New
9
Increased
21
Reduced
8
Closed
7

Top Buys

1
MDRX
Veradigm Inc. Common Stock
MDRX
+$17.9M
2
PPLI
People Inc
PPLI
+$13.4M
3
OFIX icon
Orthofix Medical
OFIX
+$12.4M
4
MITK icon
Mitek Systems
MITK
+$11.1M
5
CNNE icon
Cannae Holdings
CNNE
+$10.2M

Top Sells

1
AMBP icon
Ardagh Metal Packaging
AMBP
+$16.4M
2
TSVT
2seventy bio
TSVT
+$12.1M
3
PFSW
PFSweb, Inc.
PFSW
+$5.3M
4
TLYS icon
Tilly's
TLYS
+$4.82M
5
DXLG icon
Destination XL Group
DXLG
+$2.69M

Sector Composition

1 Healthcare 25.55%
2 Consumer Discretionary 22.11%
3 Technology 12.87%
4 Communication Services 12.45%
5 Real Estate 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FET icon
26
Forum Energy Technologies
FET
$591M
$4.31M 0.85%
194,300
+11,000
+6% +$247K
TECX
27
Tectonic Therapeutic
TECX
$657M
$3.72M 0.73%
227,848
+61,181
+37% +$1.05M
ETNB
28
DELISTED
89bio
ETNB
$3.04M 0.6%
272,500
+72,000
+36% +$662K
MURA
29
DELISTED
Mural Oncology
MURA
$2.63M 0.52%
+445,000
New +$1.79M
WVE icon
30
Wave Life Sciences
WVE
$1.18B
$2.58M 0.51%
510,000
– –
OLMA icon
31
Olema Pharmaceuticals
OLMA
$1.04B
$2.1M 0.41%
150,000
– –
BOLT icon
32
Bolt Biotherapeutics
BOLT
$7.78M
$1.74M 0.34%
77,677
+26,677
+52% +$519K
ADPT icon
33
Adaptive Biotechnologies
ADPT
$3.43B
$1.58M 0.31%
+322,000
New +$1.47M
AVIR icon
34
Atea Pharmaceuticals
AVIR
$376M
$1.55M 0.3%
508,474
+108,474
+27% +$329K
VNDA icon
35
Vanda Pharmaceuticals
VNDA
$352M
$1.22M 0.24%
+290,000
New +$1.17M
FTH
36
Faeth Therapeutics
FTH
$854M
$1.09M 0.21%
78,601
-11,399
-13% -$156K
QTTB icon
37
Q32 Bio
QTTB
$313M
$851K 0.17%
+77,737
New +$1.14M
ALGS icon
38
Aligos Therapeutics
ALGS
$37.8M
$833K 0.16%
50,200
+13,400
+36% +$230K
BDTX icon
39
Black Diamond Therapeutics
BDTX
$107M
$787K 0.15%
280,000
+75,000
+37% +$176K
NBBK icon
40
NB Bancorp
NBBK
$916M
$631K 0.12%
+46,945
New +$639K
ADVM
41
DELISTED
Adverum Biotechnologies
ADVM
$620K 0.12%
82,310
-20,190
-20% -$184K
TLYS icon
42
Tilly's
TLYS
$128M
$473K 0.09%
62,784
-599,463
-91% -$4.82M
ORKA
43
Oruka Therapeutics
ORKA
$5.28B
$458K 0.09%
22,443
-2,557
-10% -$57.4K
DFNS
44
T3 Defense Inc
DFNS
$9.21M
$76.9K 0.02%
+3,374
New +$197K
ARIZR
45
DELISTED
Arisz Acquisition Corp. Right
ARIZR
$52.5K 0.01%
250,000
– –
VHAQ.RT
46
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$11.3K ﹤0.01%
250,000
– –
LFLYW
47
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$9.96K ﹤0.01%
634,640
– –
DXLG icon
48
Destination XL Group
DXLG
$34.7M
– –
-600,000
Closed -$2.69M
MRSN
49
DELISTED
Mersana Therapeutics
MRSN
– –
-28,000
Closed -$889K
ONL
50
Orion Office REIT
ONL
$151M
– –
-474,721
Closed -$2.47M
1
2
3

Similar funds

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LM
Lincluden Management Mississauga, Ontario, Canada $936M AUM 31.43% 1-Year Est. Return
IF
Intrua Financial Houston, Texas $936M AUM 19.22% 1-Year Est. Return
PWAM
Private Wealth Asset Management Cedar Rapids, Iowa $935M AUM 17.66% 1-Year Est. Return
CM
Columbus Macro New Castle, Pennsylvania $936M AUM 12.9% 1-Year Est. Return
LJAC
L.J. Altfest & Co New York $935M AUM 27.19% 1-Year Est. Return
PO
PBCay One Dubai, United Arab Emirates $935M AUM
SH
Spear Holdings Dubai, United Arab Emirates $935M AUM 4.59% 1-Year Est. Return